Creative Medical Technology Holdings (CELZ) Prepaid Assets (2011 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Prepaid Assets of $105032.0 for Q1 2026, down 25.06% year-over-year from $140150.0 in Q1 2025, and down 24.33% quarter-over-quarter from $138804.0 in Q4 2025.
Creative Medical Technology Holdings (CELZ) Prepaid Assets (2011 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Prepaid Assets for 8 consecutive years, with $105032.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 25.06% year-over-year to $105032.0; the TTM figure through Mar 2026 stood at $105032.0 (down 25.06% YoY), while the FY2025 annual figure was $138804.0, down 27.97% from the prior year.
- Prepaid Assets fell to $105032.0 in Q1 2026 per CELZ's latest filing, from $138804.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $338120.0 in Q4 2022 and bottomed at $35036.0 in Q3 2025.
- Historically, Prepaid Assets has averaged $143308.9 across 5 years, with a median of $133945.0 in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 278.55% — and 2025, when it plunged 48.18%.
- Creative Medical Technology Holdings' Prepaid Assets stood at $338120.0 in 2022, then declined by 18.0% to $277246.0 in 2023, then slumped by 30.49% to $192707.0 in 2024, then slipped by 27.97% to $138804.0 in 2025, then fell by 24.33% to $105032.0 in 2026.
- Business Quant data shows CELZ's Prepaid Assets at $105032.0 in Q1 2026, $138804.0 in Q4 2025, and $35036.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Creative Medical Technology Holdings | 1.88 Mn | 1.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70,460.00 |
| Mar 31, 2026 | 105,032.00 |
| Dec 31, 2025 | 138,804.00 |
| Sep 30, 2025 | 35,036.00 |
| Jun 30, 2025 | 87,593.00 |
| Mar 31, 2025 | 140,150.00 |
| Dec 31, 2024 | 192,707.00 |
| Sep 30, 2024 | 67,608.00 |
| Jun 30, 2024 | 129,086.00 |
| Mar 31, 2024 | 190,564.00 |
| Dec 31, 2023 | 277,246.00 |
| Sep 30, 2023 | 61,478.00 |
| Jun 30, 2023 | 153,692.00 |
| Mar 31, 2023 | 245,906.00 |
| Dec 31, 2022 | 338,120.00 |
| Jun 30, 2022 | 64,960.00 |
| Mar 31, 2022 | 64,960.00 |
| Mar 31, 2013 | 1,181.00 |
| Dec 31, 2012 | 787.00 |
| Sep 30, 2012 | 394.00 |